A joint procurement contract between the EU and Danish manufacturer Bavarian Nordic strengthens vaccine preparedness against ...

GLP-1 receptor agonists affect sexual function differently across individuals and influencing libido and hormone levels in ...

Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.

In a phase 2 trial, firsekibart — an IL-1 beta antibody — outperforms colchicine in preventing acute gout flares over 12 ...

Older, impulsive teens with prior substance use are more likely to be open to vaping or smoking, while strong parental ...

The increasing frequency of extreme weather events and continued rise in global temperatures may affect neurodevelopment in ...

The long-awaited Canadian approval of lecanemab has shifted physicians’ approach to Alzheimer’s disease, addressing previous ...

An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...

Patients with or without rheumatoid arthritis treated with immune checkpoint inhibitors show no significant difference in the ...

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

A French-American team reports that Carba1 prevents chemotherapy-induced neuropathy in preclinical models while preserving ...

Individuals with systemic sclerosis have a higher risk for hematologic malignancies than those without the condition, with ...